Danish study with 360,000 participants to investigate the effect of vaccine against RS virus. (Archive photo). Photo: Tatan Syuflana/Ritzau Scanpix
360,000 Danes to prove RSV vaccine effectiveness
A Danish study on the effects of vaccination against the RSV illness is set to expand, according to Pfizer, the project’s sponsor. Initially, over 130,000 Danes over 60 participated, showing that vaccination reduced hospitalization risk by more than 80%. The goal now is to involve 360,000...
Get full access to Danish News in English
Gain exclusive access to daily news updates in English pertaining to Denmark with a Ritzau News subscription.
Already a subscriber?